EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Multiple sclerosis: economic burden, therapeutic advances, and future forecasts in the Middle East and North Africa region

Radwa Ahmed Batran iD, Mohab Kamel, Ayman Bahr, Joseph Waheb, Ahmed Khalil, Mohamed Elsokary

Expert Review of Pharmacoeconomics & Outcomes Research · 2024

DOI: 10.1080/14737167.2024.2364832 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2024. Verfasst von Radwa Ahmed Batran und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs Department, Volaris LLC, Dubai, UAE. Hauptthemen laut MEDLINE: Multiple Sclerosis, Cost of Illness, Forecasting, Health Care Costs. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 87 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Multiple sclerosis (MS) is a persistent condition characterized by immune-mediated processes in the central nervous system, affecting around 2.8 million individuals globally. While historically less prevalent in the Middle East and North Africa (MENA) region, recent trends mirror the global rise in MS. AREA COVERED: The impact of MS is substantial, particularly in the MENA region, with costs per patient surpassing nominal GDP per capita in certain countries. Disease-modifying therapies aim to alleviate MS effects, but challenges persist, especially in managing progressive MS as it shifts from inflammatory to neurodegenerative phases. Limited resources in the MENA region hinder care delivery, though awareness initiatives and multidisciplinary centers are emerging. Contrary to global projections of a decline in the MS market, the MENA region is poised for growth due to increased prevalence, healthcare expenditures, and infrastructure investments. EXPERT OPINION: This review underscores the urgent necessity for effective treatments, robust disease management, and early diagnosis in tackling MS's repercussions in the MENA region. Bolstering resources tailored to MS patients and elevating the quality of care stand as pivotal strategies for enhancing health outcomes in this context. Taking decisive action holds the key to enhancing the overall well-being of individuals grappling with MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple SclerosisCost of IllnessForecastingHealth Care CostsHumansMiddle EastAfrica, NorthernPrevalenceDelivery of Health CareHealth ExpendituresEarly DiagnosisDisease ManagementQuality of Health Care

Stichwörter der Autor:innen

Middle East and North AfricaMultiple sclerosiseconomic burdenmarket forecaststherapeutic advances

Autor:innen und Institutionen

  • Medical Affairs Department, Volaris LLC, Dubai, UAE.
  • Clinical Pharmacy & HEOR, Cairo University Hospitals, Cairo, Egypt.
  • Medical Affairs Department, Volaris LLC, Jeddah, Saudi Arabia.
  • Medical Affairs Department, Volaris LLC, Cairo, Egypt.

ORCID-Profile: Radwa Ahmed Batran

Zitieren

APA

Batran, R. A., Kamel, M., Bahr, A., Waheb, J., Khalil, A., & Elsokary, M. (2024). Multiple sclerosis: economic burden, therapeutic advances, and future forecasts in the Middle East and North Africa region. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2024.2364832

Vancouver

Batran RA, Kamel M, Bahr A, Waheb J, Khalil A, Elsokary M. Multiple sclerosis: economic burden, therapeutic advances, and future forecasts in the Middle East and North Africa region. Expert Review of Pharmacoeconomics & Outcomes Research. 2024. doi:10.1080/14737167.2024.2364832

BibTeX
@article{Batran2024,
  author = {Batran, Radwa Ahmed and Kamel, Mohab and Bahr, Ayman and Waheb, Joseph and Khalil, Ahmed and Elsokary, Mohamed},
  title = {Multiple sclerosis: economic burden, therapeutic advances, and future forecasts in the Middle East and North Africa region},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2024},
  doi = {10.1080/14737167.2024.2364832}
}
Kostenlos starten →